On Sep 8, 2021 PetMedix closed a Series B round and raised £27,000,000 from Cambridge Innovation Capital, Digitalis Ventures, Kyoritsu Corporation, Parkwalk Advisors, Tencent, featuring […]
Series B – ADARx Pharmaceuticals
On Sep 8, 2021 ADARx Pharmaceuticals closed a Series B round and raised $75,000,000 from Lilly Asia Ventures, OrbiMed, Sirona Capital, SR One, featuring lead […]
Series A – A-Alpha Bio
On Sep 8, 2021 A-Alpha Bio closed a Series A round and raised $20,000,000 from Lux Capital, Madrona Venture Group, Perceptive Advisors, featuring lead investors […]
Series A – Replicate Bioscience
On Sep 8, 2021 Replicate Bioscience closed a Series A round and raised $40,000,000 from Apple Tree Partners, featuring lead investors Apple Tree Partners. About […]
Series B – Attralus
On Sep 8, 2021 Attralus closed a Series B round and raised $116,000,000 from Janus Henderson Investors, Logos Capital, Redmile Group, Samsara BioCapital, Sarissa Capital […]
Series B – PetMedix
On Sep 8, 2021 PetMedix closed a Series B round and raised £27,000,000 from Cambridge Innovation Capital, Digitalis Ventures, Kyoritsu Corporation, Parkwalk Advisors, Tencent, featuring […]
Series B – ADARx Pharmaceuticals
On Sep 8, 2021 ADARx Pharmaceuticals closed a Series B round and raised $75,000,000 from Lilly Asia Ventures, OrbiMed, Sirona Capital, SR One, featuring lead […]
Series A – A-Alpha Bio
On Sep 8, 2021 A-Alpha Bio closed a Series A round and raised $20,000,000 from Lux Capital, Madrona Venture Group, Perceptive Advisors, featuring lead investors […]
Series A – Via Nova Therapeutics
On Sep 7, 2021 Via Nova Therapeutics closed a Series A round and raised $20,000,000 from Aditum Bio, featuring lead investors Aditum Bio. About the […]
Series A – EnteroBiotix
On Sep 7, 2021 EnteroBiotix closed a Series A round and raised £15,500,000 from Kineticos Ventures, Scottish Enterprise, SIS Ventures, Thairm Bio, featuring lead investors […]
